A Tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: Secondary analysis of clinical trial data

BMJ Open

Volumn 5, Issue 2, 2015, Pages

  Alassaad, Anna ^a,b   Melhus, Håkan ^a   Hammarlund Udenaes, Margareta ^a   Bertilsson, Maria ^c   Gillespie, Ulrika ^b   Sundström, Johan ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; OPIATE; DRUG; GASTROINTESTINAL AGENT; NARCOTIC ANALGESIC AGENT;

AGED; AGED HOSPITAL PATIENT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; DISCRIMINANT ANALYSIS; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INAPPROPRIATE PRESCRIBING; INTERNAL VALIDITY; KIDNEY FUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION APPROPRIATENESS INDEX; MORTALITY; NEOPLASM; NURSING HOME; PEPTIC ULCER; PHARMACIST; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SCORING SYSTEM; SCREENING TOOL OF OLDER PERSON PRESCRIPTION; SCREENING TOOL TO ALERT DOCTORS TO RIGHT TREATMENT; SECONDARY ANALYSIS; VALIDATION PROCESS; VERY ELDERLY; ACUTE DISEASE; ADVERSE DRUG REACTION; CLINICAL PRACTICE; CONTROLLED STUDY; ELDERLY CARE; GERIATRICS; HOSPITAL; HOSPITALIZATION; INTERNAL MEDICINE; PRESCRIPTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARDS; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ACUTE DISEASE; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; DRUG PRESCRIPTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GASTROINTESTINAL AGENTS; GERIATRICS; HEALTH SERVICES FOR THE AGED; HOSPITALIZATION; HOSPITALS; HUMANS; INTERNAL MEDICINE; MALE; MORTALITY; PATIENT READMISSION; PHARMACEUTICAL PREPARATIONS; PRACTICE PATTERNS, PHYSICIANS'; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84923658688     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007259     Document Type: Article

References (48)

1. Kansagara D, Englander H, Salanitro A, et al. Risk prediction models for hospital readmission: a systematic review. JAMA 2011;306:1688-98.
2. Vest JR, Gamm LD, Oxford BA, et al. Determinants of preventable readmissions in the United States: a systematic review. Implement Sci 2010;5:88.
3. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992;33:61-8.
4. Mannesse CK, Derkx FH, de Ridder MA, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000;29:35-9.
5. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
7. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004;57:121-6.
8. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989;321:303-9.
9. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-6.
10. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
11. Gallagher P, Ryan C, Byrne S, et al . STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46:72-83.
12. Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007;63:725-31.
13. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997;156:385-91.
14. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Ärztebl Int 2010;107:543-51.
15. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994;47:891-6.
16. Sammanhållen vård och omsorg om de mest sjuka äldre 2014.axd. http://wwwskl.se/BinaryLoader.axd?OwnerID=dbf2c094-6870-4e16-8fbd-7db59f326f72&OwnerType=0&Name=Property EmbeddedImg-8696d165-8969-485b-a0cb-d17e48806b5c& FileName=Sammanh%c3%a5llen+v%c3%a5rd+och+omsorg+om +de+mest+sjuka+%c3%a4ldre+2014+-+%c3%b6verenskommelse. pdf&Attachment=False (accessed 26 May 2014).
17. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.
18. Fialová D, Topinková E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293:1348-58.
19. Gallagher P, Baeyens J-P, Topinkova E, et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009;38:603-6.
20. Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007;36:632-8.
21. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151:1825-32.
22. Gillespie U, Alassaad A, Hammarlund-Udenaes M, et al. Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization-analyses from a randomized controlled trial. PLoS ONE 2013;8:e62401.
23. Laroche ML, Charmes JP, Bouthier F, et al. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009;85:94-7.
24. Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012;5:CD008165.
25. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84.
26. Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 2009;169:894-900.
27. WHOCC-Structure and principles. http://www.whocc.no/atc/ structure-and-principles/ (accessed 21 Aug 2014).
28. Sullivan LM, Massaro JM, D 'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-60.
29. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-53.
30. Grønnesby JK, Borgan O. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal 1996;2:315-28.
31. Harrell FE. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer New York, 2001.
32. Burns R, Nichols LO. Factors predicting readmission of older general medicine patients. J Gen Intern Med 1991;6:389-93.
33. Smith DM, Giobbie-Hurder A, Weinberger M, et al. Predicting non-elective hospital readmissions: a multi-site study. Department of Veterans Affairs Cooperative Study Group on Primary Care and Readmissions. J Clin Epidemiol 2000;53:1113-18.
34. Stäck P, Forsberg B, Högberg M, et al. Risken för akut återinläggning kan förutsägas. http://www.lakartidningen.se/ Functions/OldArticleView.aspx?articleId=18930 (accessed 11 Jun 2014).
35. Phillips RS, Safran C, Cleary PD, et al. Predicting emergency readmissions for patients discharged from the medical service of a teaching hospital. J Gen Intern Med 1987;2:400-5.
36. Marcantonio ER, McKean S, Goldfinger M, et al. Factors associated with unplanned hospital readmission among patients 65 years of age and older in a Medicare managed care plan. Am J Med 1999;107:13-17.
37. VanWalraven C, Dhalla IA, Bell C, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ 2010;182:551-7.
38. Hasan O, Meltzer DO, Shaykevich SA, et al. Hospital readmission in general medicine patients: a prediction model. J Gen Intern Med 2010;25:211-19.
39. Donzé J, Aujesky D, Williams D, et al. Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model. JAMA Intern Med 2013;173:632-8.
40. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011;89:845-54.
41. Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008;31:42-51.
42. Gordon AL, Franklin M, Bradshaw L, et al. Health status of UK care home residents: a cohort study. Age Ageing 2014;43:97-103.
43. Masclee GMC, Sturkenboom MCJM, Kuipers EJ. A benefit-risk assessment of the use of proton pump inhibitors in the elderly. Drugs Aging 2014;31:263-82.
44. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 2006;113:456-62.
45. Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol 2014;77:756-66.
46. Boockvar KS, Liu S, Goldstein N, et al. Prescribing discrepancies likely to cause adverse drug events after patient transfer. Qual Saf Health Care 2009;18:32-6.
47. Coleman EA, Smith JD, Raha D, et al. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med 2005;165:1842-7.
48. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30.